Figure 2From: Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism Lipid profile changes in patients receiving NNRTI therapy. No differences were observed between genotypes in regards to serum triglyceride (A) or total cholesterol (B) concentrations. However, carriers of the A allele (closed circles) had significantly decreased HDL-cholesterol values when compared with non-carriers (open circles) at 3, 6, and 12 months after treatment initiation (C). * indicates p < 0.05.Back to article page